Background: Augmented reality (AR) superimposes virtual objects onto a real-world environment, allowing users to interact in real time. As AR has become widely used, its integration into smartphones or tablets has enabled mobile augmented reality (MAR) experiences. AR has been adopted in many industries, and the literature has highlighted its applications in academic and clinical settings, particularly in enhancing visualization, communication, and learning. Objective: This study investigated the potential of MAR as a mobile health tool to enhance shared decision-making (SDM) in thoracic surgery by increasing patient understanding and engagement during medical consultations. Methods: A randomized crossover clinical trial was conducted at the Tri-Service General Hospital in Taiwan. Participants scheduled for thoracic surgery were enrolled and randomized in a crossover design. The MAR intervention incorporated patient-specific 3D anatomical models that were reconstructed from computed tomography imaging to facilitate understanding and support SDM. The impact of each counseling approach on SDM was evaluated using postintervention questionnaires. Results: A total of 47 participants were enrolled in this study. After analyzing the data, we found that patients in the MAR group showed significantly higher scores compared to those in the traditional counseling group (P<.001) during the SDM process. Moreover, patients reported higher satisfaction levels and found the visual objects helpful for understanding tumor location and surgical procedures. Conclusions: This study demonstrated that MAR counseling significantly enhanced patients’ comprehension of thoracic conditions and increased their active engagement in the SDM process (P<.001). The integration of patient-specific 3D anatomical models into MAR technology provided an intuitive method for critical medical information. This digital approach not only enhanced personalization in medical communication but also reinforced patient education about their health care conditions. These findings suggest that MAR counseling represents a promising approach for promoting patient-centered care in thoracic surgery and has potential applications across various clinical domains. Trial Registration: ClinicalTrials.gov NCT07062393; https://clinicaltrials.gov/study/NCT07062393
Background: The aim of this study was to verify the importance and the timing of endobronchial ultrasound with transbronchial biopsy (EBUS TBNA) among lung adenocarcinoma patients after radical resection. Methods: We retrospectively reviewed consecutive patients with non-small cell lung cancer (NSCLC) who had ever received radical resection from January 2002 to December 2021. The patients were divided into two groups, with and without EBUS TBNA, for diagnosis or staging. Results: Of 2018 patients with NSCLC, after surgical resection of lung tumors, there were 232 with recurrences. Under multivariate Cox regression analysis, patients with recurrences who received EBUS TBNA had a statistically higher mean maximum standardized uptake value (SUVmax) (hazard ratio (HR) = 1.115, confidence interval (CI) = 1.004–1.238, p = 0.042) and better survival (HR = 5.966, CI = 1.473–24.167, p = 0.012). Although KM survival analysis showed no statistically significant difference between groups with and without EBUS TBNA (p = 0.072) of lung adenocarcinoma patients with recurrences, patients with mutated epidermal growth factor receptor (EGFR) showed significantly better survival than wild-type EGFR (p = 0.007). Conclusions: The clinical practice of EBUS TBNA is not only for diagnosis, but also for nodal staging. We found that lung adenocarcinoma patients with recurrences who received EBUS TBNA had better overall survival. Therefore, EBUS TBNA is a reliable and feasible tool that could be used in lung adenocarcinoma patients with recurrences for early diagnosis and for adequate tissue specimens for further molecular analysis.
Background: The integration of AI into intraoperative surgical imaging represents an emerging frontier in digital health. Despite advances in preoperative computed tomography (CT)–based surgical planning, real-time translation of imaging data into actionable intraoperative guidance remains limited by CT-to-body divergence—a fundamental information gap between preoperative digital models and the dynamic surgical field. This divergence, driven by lung deflation under anesthesia and positional changes, represents a critical digital-to-physical registration challenge that current preoperative imaging workflows fail to address in real time. Objective: This study aimed to evaluate the clinical feasibility, localization success, and safety of the LungVision system—an AI-augmented fluoroscopic navigation platform—for real-time intraoperative localization of small pulmonary nodules during thoracoscopic surgery. Methods: A prospective single-center study enrolled 14 patients with pulmonary nodules requiring localization prior to thoracoscopic resection between January 2024 and December 2024. The platform comprises a passive radiopaque positioning board, an AI-powered computing unit for real-time image processing, and a tablet-based interface for procedural planning and augmented visualization. All patients received dual localization with either preoperative CT-guided dye injection or Archimedes virtual bronchoscopic navigation followed by intraoperative localization with the LungVision system and video-assisted thoracoscopic surgery. Demographic data, lesion characteristics, procedural performance, and procedure-related complications were recorded. Results: The mean patient age was 57.2 (SD 9.2) years, and 92.9% (13/14) were nonsmokers. Most nodules were peripherally located (12/14, 85.7%), with a mean diameter of 9.3 (SD 5.3) mm and a mean CT attenuation of −320.1 (SD 334.9) Hounsfield units. LungVision successfully localized all target lesions intraoperatively, with a mean navigation time of 38.6 (SD 19.5) minutes. Complete resection was achieved in all cases, and 71.4% (10/14) of nodules were pathologically malignant. No intraoperative or localization-related complications were observed. The system was integrated into the existing operating room without additional infrastructure modifications. Conclusions: In this prospective study, the LungVision system achieved successful intraoperative localization of small, hypodense pulmonary nodules using a bronchoscopic approach integrated with conventional C-arm fluoroscopy. These findings support the feasibility of the technique and provide preliminary evidence on its use in thoracoscopic resection workflows. Larger studies are needed to further evaluate its clinical performance and implementation in diverse practice settings. Trial Registration: ClinicalTrials.gov NCT07682012; https://clinicaltrials.gov/study/NCT07682012
BACKGROUND The integration of AI into intraoperative surgical imaging represents an emerging frontier in digital health. Despite advances in preoperative computed tomography (CT)–based surgical planning, real-time translation of imaging data into actionable intraoperative guidance remains limited by CT-to-body divergence—a fundamental information gap between preoperative digital models and the dynamic surgical field. This divergence, driven by lung deflation under anesthesia and positional changes, represents a critical digital-to-physical registration challenge that current preoperative imaging workflows fail to address in real time. OBJECTIVE This study aimed to evaluate the clinical feasibility, localization success, and safety of the LungVision system—an AI-augmented fluoroscopic navigation platform—for real-time intraoperative localization of small pulmonary nodules during thoracoscopic surgery. METHODS A prospective single-center study enrolled 14 patients with pulmonary nodules requiring localization prior to thoracoscopic resection between January 2024 and December 2024. The platform comprises a passive radiopaque positioning board, an AI-powered computing unit for real-time image processing, and a tablet-based interface for procedural planning and augmented visualization. All patients received dual localization with either preoperative CT-guided dye injection or Archimedes virtual bronchoscopic navigation followed by intraoperative localization with the LungVision system and video-assisted thoracoscopic surgery. Demographic data, lesion characteristics, procedural performance, and procedure-related complications were recorded. RESULTS The mean patient age was 57.2 (SD 9.2) years, and 92.9% (13/14) were nonsmokers. Most nodules were peripherally located (12/14, 85.7%), with a mean diameter of 9.3 (SD 5.3) mm and a mean CT attenuation of −320.1 (SD 334.9) Hounsfield units. LungVision successfully localized all target lesions intraoperatively, with a mean navigation time of 38.6 (SD 19.5) minutes. Complete resection was achieved in all cases, and 71.4% (10/14) of nodules were pathologically malignant. No intraoperative or localization-related complications were observed. The system was integrated into the existing operating room without additional infrastructure modifications. CONCLUSIONS In this prospective study, the LungVision system achieved successful intraoperative localization of small, hypodense pulmonary nodules using a bronchoscopic approach integrated with conventional C-arm fluoroscopy. These findings support the feasibility of the technique and provide preliminary evidence on its use in thoracoscopic resection workflows. Larger studies are needed to further evaluate its clinical performance and implementation in diverse practice settings. CLINICALTRIAL ClinicalTrials.gov NCT07682012; https://clinicaltrials.gov/study/NCT07682012
BACKGROUND Augmented reality (AR) superimposes virtual objects onto a real-world environment, allowing users to interact in real time. As AR has become widely used, its integration into smartphones or tablets has enabled mobile augmented reality (MAR) experiences. AR has been adopted in many industries, and the literature has highlighted its applications in academic and clinical settings, particularly in enhancing visualization, communication, and learning. OBJECTIVE This study investigated the potential of MAR as a mobile health tool to enhance shared decision-making (SDM) in thoracic surgery by increasing patient understanding and engagement during medical consultations. METHODS A randomized crossover clinical trial was conducted at the Tri-Service General Hospital in Taiwan. Participants scheduled for thoracic surgery were enrolled and randomized in a crossover design. The MAR intervention incorporated patient-specific 3D anatomical models that were reconstructed from computed tomography imaging to facilitate understanding and support SDM. The impact of each counseling approach on SDM was evaluated using postintervention questionnaires. RESULTS A total of 47 participants were enrolled in this study. After analyzing the data, we found that patients in the MAR group showed significantly higher scores compared to those in the traditional counseling group (P<.001) during the SDM process. Moreover, patients reported higher satisfaction levels and found the visual objects helpful for understanding tumor location and surgical procedures. CONCLUSIONS This study demonstrated that MAR counseling significantly enhanced patients’ comprehension of thoracic conditions and increased their active engagement in the SDM process (P<.001). The integration of patient-specific 3D anatomical models into MAR technology provided an intuitive method for critical medical information. This digital approach not only enhanced personalization in medical communication but also reinforced patient education about their health care conditions. These findings suggest that MAR counseling represents a promising approach for promoting patient-centered care in thoracic surgery and has potential applications across various clinical domains. CLINICALTRIAL ClinicalTrials.gov NCT07062393; https://clinicaltrials.gov/study/NCT07062393